A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

In SELECT, semaglutide was associated with a 41% reduction in major CV events within 6 months — ie, before weight loss or ...

FuturHealth offers both compounded semaglutide and FDA-approved name-brand options like Wegovy and Ozempic. For most users, ...

Limited effectiveness, weight regain, and high prevalence of adverse events are the three key limitations of semaglutide ...

While natural approaches to raising GLP-1 are not as potent as medications, they provide a drug-free approach to weight loss ...

A global trial reveals tirzepatide helps people lose more weight faster than semaglutide. This breakthrough could change ...

New research published in the American Journal of Health-System Pharmacy suggests a possible link between the GLP-1 drug ...

Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or ...

New animal research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May), reveals ...

The benefit was seen as soon as 3 months. Investigators say there should be no delaying treatment for eligible patients.

New research reveals that semaglutide significantly improves liver health in MASH patients. A new study published in the New ...